TNF and lymphoma: In 2020, a meta-analysis including 4 observational studies confirmed that anti-TNF therapy was associated with a higher rate of lymphoma than that in IBD patients unexposed to anti-TNFs with a pooled IRR of 1.52/1000 PY [75].